A study in the journal Cancer showed that women with cervical cancer and early post-therapy human papillomavirus clearance had 76.9% two-year pelvic control and 80.9% two-year overall survival, compared with 50.2% two-year pelvic control and 52.2% two-year OS among those with persistent HPV expression. Researchers also found that among those with complete response on post-therapy PET and early HPV clearance, the two-year OS rate was 95.6%, compared with 66.7% among those with persistent expression, while the lowest two-year OS rate was found among those with persistent expression and no PET complete response.
Early HPV clearance boosts cervical cancer outcomes
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.